Center for Antibody Drug Development

Introduction

Antibody Drug Development Center aims to develop monoclonal antibody drugs with completely independent intellectual property rights by using world-class monoclonal antibody technologies to treat and diagnose cancer and inflammatory diseases. Its mission is to foster independent innovation, improve the capability of monoclonal antibody drug development of our nation, and enhance the competitiveness of the pharmaceutical industry of our nation. 

Main Research Projects

  • Research and development of Car-T new technologies of cell therapy 
  • Research and development of Macromolecular drugs (antibodies and vaccines) 
  • Research of the pathogenesis of major diseases 
  • Early diagnosis and detection technology 
  • Research and development of small molecule drugs 
  • Development of Reagents and formulations 

Researchers

  • CHEN Youhai

    Title:Chief Scientists
    Email:yh.chen@siat.ac.cn
    Areas of Interest:Pathogenesis of malignant tumor

  • WANG Pu

    Title:Researcher Professor
    Email:pu.wang@siat.ac.cn
    Areas of Interest:Therapeutic intervention

  • RUAN Qingguo

    Title:Researcher Professor
    Email:qg.ruan@siat.ac.cn
    Areas of Interest:Molecular mechanisms

  • CHANG Junlei

    Title:Researcher Professor
    Email:jl.chang@siat.ac.cn
    Areas of Interest:Molecular mechanisms controlling

  • WAN Xiaochun

    Title:Researcher Professor
    Email:075586585218
    Areas of Interest:Infectious diseases

  • YANG Xiaolu

    Title:Researcher Professor
    Email:yangxl@siat.ac.cn
    Areas of Interest:Tumor cell signal transduction


  • 1